Literature DB >> 29492743

Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China.

Liu Liu1,2, Shunping Li3,4, Yue Zhao5, Jianglin Zhang6, Gang Chen7.   

Abstract

PURPOSE: To investigate the validity of direct and indirect health state utility (HSU) and subjective well-being measures in psoriasis vulgaris patients.
METHODS: A convenience sampling framework was used to successively recruit patients with psoriasis vulgaris from the outpatient clinics of a tertiary hospital in Changsha, Central South China. Participants completed time trade-off (TTO), standard gamble (SG), the five-level EQ-5D (EQ-5D-5L), the WHO-5 well-being index, and the psoriasis disability index (PDI). The concurrent and known-groups validity of HSUs and well-being index in psoriasis patients were firstly studied. The agreements among HSUs and the relationship between HSU and well-being measures were further explored.
RESULTS: A valid sample of 343 patients was analyzed. Mean HSU and well-being scores elicited from the EQ-5D-5L/TTO/SG and WHO-5 were 0.90/0.85/0.88 and 13.69, respectively. The Spearman correlation (concurrent validity) was the strongest between PDI and WHO-5 (r = 0.45), followed by with EQ-5D-5L (0.38), SG (r = 0.20), and the TTO (r = 0.18). The pairwise intraclass correlation coefficients among the three HSU measures were < 0.30. The known-groups validity was evident in all measures except for the SG. Exploratory factor analysis further suggests a complementary relationship between the EQ-5D-5L and WHO-5.
CONCLUSIONS: There is a poor agreement between direct and indirect methods on measuring HSU with psoriasis vulgaris. Results from this study recommend that the EQ-5D-5L is the most preferred method to elicit HSU from psoriasis vulgaris patients in mainland China. It is important to further analyze the subjective well-being in addition to the HSU to fully understand the impact of psoriasis.

Entities:  

Keywords:  EQ-5D-5L; Health state utility; Psoriasis vulgaris; Standard gamble; Time trade-off; Well-being

Mesh:

Year:  2018        PMID: 29492743     DOI: 10.1007/s11136-018-1819-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  30 in total

Review 1.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

2.  Distribution of psoriasis in China: a nationwide screening.

Authors:  C G Shao; G W Zhang; G C Wang
Journal:  Proc Chin Acad Med Sci Peking Union Med Coll       Date:  1987

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA.

Authors:  Susan Clemens; Nelufa Begum; Catherine Harper; Jennifer A Whitty; Paul A Scuffham
Journal:  Qual Life Res       Date:  2014-03-28       Impact factor: 4.147

Review 5.  The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis.

Authors:  Jochen Schmitt; Gottfried Wozel
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

6.  Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema.

Authors:  L Lundberg; M Johannesson; M Silverdahl; C Hermansson; M Lindberg
Journal:  Br J Dermatol       Date:  1999-12       Impact factor: 9.302

7.  The WHO (Ten) Well-Being Index: validation in diabetes.

Authors:  P Bech; C Gudex; K S Johansen
Journal:  Psychother Psychosom       Date:  1996       Impact factor: 17.659

8.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

9.  Time trade-off: one methodology, different methods.

Authors:  Arthur E Attema; Yvette Edelaar-Peeters; Matthijs M Versteegh; Elly A Stolk
Journal:  Eur J Health Econ       Date:  2013-07

Review 10.  New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.

Authors:  Andrew C Palfreeman; Kay E McNamee; Fiona E McCann
Journal:  Drug Des Devel Ther       Date:  2013-03-27       Impact factor: 4.162

View more
  5 in total

1.  Validity and Psychometric Evaluation of the Chinese Version of the 5-Item WHO Well-Being Index.

Authors:  Sai-Fu Fung; Chris Yiu Wah Kong; Yi-Man Liu; Qian Huang; Zike Xiong; Zhiquan Jiang; Fangfang Zhu; Zhenting Chen; Kun Sun; Huiqin Zhao; Ping Yu
Journal:  Front Public Health       Date:  2022-03-30

Review 2.  Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review.

Authors:  Xinyu Qian; Rachel Lee-Yin Tan; Ling-Hsiang Chuang; Nan Luo
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

3.  Filling the psycho-social gap in the EQ-5D: the empirical support for four bolt-on dimensions.

Authors:  Gang Chen; Jan Abel Olsen
Journal:  Qual Life Res       Date:  2020-07-09       Impact factor: 4.147

4.  Extending the EQ-5D: the case for a complementary set of 4 psycho-social dimensions.

Authors:  Gang Chen; Jan Abel Olsen
Journal:  Qual Life Res       Date:  2022-09-20       Impact factor: 3.440

5.  Measurement properties of the ICECAP-A capability well-being instrument among dermatological patients.

Authors:  Fanni Rencz; Ariel Z Mitev; Balázs Jenei; Valentin Brodszky
Journal:  Qual Life Res       Date:  2021-08-09       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.